Jan 7, 2025 · Ursofalk is used for the treatment of Cholestasis (Jaundice), Viral Hepatitis, Alcoholic Fatty Liver, Primary Billiary Cirrhosis (PBC), Primary Sclerosing Cholangitis (PSC), Dissolution of Gallstones and Non-Alcoholic Steato Hepatitis (NASH).

Ursofalk 250mg Capsule is used to dissolve certain gallstones and prevent them from forming. It is also used to treat a type of liver disease called primary biliary cirrhosis. It helps break down the cholesterol that has converted into stones in your gallbladder thereby dissolving the stones.

The administration of Ursofalk Capsules is based on body weight and the condition being treated. Use in children (6 to 18 years) for treatment of liver disease associated

Ursodeoxycholic acid, the active substance in Ursofalk capsules, is a naturally-occurring bile acid. Small amounts are found in human bile. to dissolve gallstones caused by excess cholesterol in the gall bladder where the gallstones are not visible on a plain x-ray (gallstones that are visible will not dissolve) and not more than 15 mm in diameter.

Feb 3, 2025 · The daily dose depends on body weight, and ranges from 3 to 7 capsules (14 ± 2 mg UDCA per kg of body weight). For the first 3 months of treatment, Ursofalk capsules should be taken divided over the day. With improvement of the liver values the daily dose may be taken once daily in the evening.

URSOFALK is indicated in the treatment of chronic cholestatic liver diseases. For PBC and chronic cholestatic liver diseases other than CF and PSC, the dosage of 12 – 16 mg/kg body weight/day of ursodeoxycholic acid is recommended. For CF-related cholestasis, the recommended dose is 20 mg/kg/day of ursodeoxycholic acid.

1. What Ursofalk Capsules are and what they are used for Ursodeoxycholic acid (UDCA), the active substance in Ursofalk Capsules, is a naturally occurring bile acid. Small amounts are found in human bile. Ursofalk Capsules are used: – for the treatment of a condition where the bile ducts in the liver become damaged; leading to a build-up of bile.

URSOFALK may be used to treat liver diseases such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and cystic fibrosis (CF)-related cholestasis. However, your doctor may prescribe this medicine for another use. If you or …

Jan 29, 2025 · The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.

Nov 27, 2024 · Health Products Regulatory Authority 27 November 2024 CRN00F85Z Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ursofalk 250 mg Hard Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 250mg of ursodeoxycholic acid (UDCA) as the active substance.